超20亿美元交易官宣终止,宜明昂科:对下一步BD充满信心

澎湃新闻
Jan 07

“坦率讲,我个人对目前把全球权益拿回来是感到非常高兴的。”在1月7日早上的电话会上,宜明昂科生物医药技术(上海)股份有限公司(宜明昂科,1541.HK)创始人、董事长田文志表达了上述感受。  1月6日晚间,宜明昂科宣布与Axion Bio, Inc.(简称“Axion”,Instil Bio, Inc. 的全资子公司)已签署协议终止双方关于IMM2510/AXN-2510和IMM27M/AXN-...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10